Search results
Veterinary Biologics Market Projected to Surpass USD 24 Billion by 2034 at a 6.3% of CAGR
PharmiWeb· 3 days agoThe veterinary biologics market is poised for significant expansion, with an estimated valuation of USD 13,140.6 million in 2024. According to recent market analysis, the market is projected ...
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market is expected to grow at a CAGR of 11% and re
PharmiWeb· 3 days agoThe fight against breast cancer receives a crucial boost with advancements in diagnostic tools. Future Market Insights predicts the ESR1 Mutated Metastatic Breast Cancer Diagnostics Market to ...
Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates
Zacks via Yahoo Finance UK· 3 days agoCartesian (RNAC) announced that the phase IIb study in MG patients has achieved its primary...
A New Alzheimer’s Drug May Be the Most Effective One Yet
Time via Yahoo News UK· 3 days agoDonanemab’s effectiveness likely comes from its ability to specifically target the toxic plaques of...
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo Finance UK· 4 days agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
The shock realities of babies with deadly virus as experts issue warning
The Irish Sun· 4 days agoA PHARMACIST is campaigning for RSV immunisations for all babies this winter as experts warn of the...
FDA approves second Alzheimer’s drug that can modestly slow disease
Daily Echo· 4 days agoThe Food and Drug Administration (FDA) approved Eli Lilly’s Kisunla, known chemically as donanemab, for mild or early cases of dementia caused by Alzheimer’s. It is only the second drug that ...
FDA approves second Alzheimer’s drug that can modestly slow disease
Irish Examiner· 4 days agoRolling coverage of the international stories of interest to our readers
'Game-changing' Alzheimer's drug is approved in US - as UK decision imminent
The Sun· 4 days ago"We are hopeful that a decision will be made later this year for Great Britain." Donanemab, made by...
Vestibular hair cells are more prone to damage by excessive acceleration insult in the mouse with...
Nature· 4 days agoAll of the animal experimental procedures and a study enrolling humans were approved by the Yonsei University Health System Institutional Animal Care and Use Committee (approval No. 2016-0254 ...